載入...
Total body irradiation-based haploidentical hematopoietic stem cell transplantation using posttransplant cyclophosphamide after administration of inotuzumab ozogamicin: A case report
Owing to the poor prognosis of relapsed or refractory acute lymphoblastic leukemia (ALL), hematopoietic stem cell transplantation (HSCT) followed by effective salvage therapy is required. Inotuzumab ozogamicin (INO) was developed for ALL refractory to standard chemotherapy. However, previous reports...
Na minha lista:
| 發表在: | Leuk Res Rep |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Elsevier
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8111671/ https://ncbi.nlm.nih.gov/pubmed/34007785 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lrr.2021.100241 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|